Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter

Clinical Cancer Research

Volumn 10, Issue 10, 2004, Pages 3535-3541

  Jacob, Dietmar ^a   Davis, John ^a,b   Zhu, Hongbo ^a   Zhang, Lidong ^a   Teraishi, Fuminori ^a   Wu, Shuhong ^a   Marini III, Frank C ^a   Fang, Bingliang ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; DRUG POTENCY; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME; MOUSE; NONHUMAN; PANCREAS CANCER; PANCREAS TUMOR; PRIORITY JOURNAL; PROMOTER REGION; STEM CELL; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD34; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL LINE, TUMOR; CELL SEPARATION; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE THERAPY; GENETIC VECTORS; HEPATOCYTES; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; MODELS, GENETIC; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PANCREATIC NEOPLASMS; PROMOTER REGIONS (GENETICS); STEM CELLS; TELOMERASE; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSGENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2542454709     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0512     Document Type: Article

References (29)

1. World Health Organization. World cancer report. Lyon: IARC Press; 2003.
2. Kausch W. Das Carcinom der Papilla Duodeni und seine radikale Entfernung. Beitraege zur klinischen Chirurgie 1912;78:439-86.
3. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567-79.
4. Yeo TP, Hruban RH, Leach SD, et al. Pancreatic cancer. Curr Prob Cancer 2002;26:176-275.
5. Gudjonsson B. Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284-303.
6. Blaszkowsky L. Treatment of advanced and metastatic pancreatic cancer. Front Biosci 1998;3:E214-25.
7. Bouvet M, Bold RJ, Lee J, et al. Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer. Ann Surg Oncol 1998;5:681-8.
8. Pearson AS, Bouvet M, Evans DB, Roth JA. Gene therapy and pancreatic cancer. Front Biosci 1998;3:E230-7.
9. Kagawa S, He C, Gu J, et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001;61:3330-8.
10. Lin T, Gu J, Zhang L, et al. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effect on primary human hepatocytes. Cancer Res 2002;62:3620-5.
11. Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. J Immunol 2000;165:2886-94.
12. Huang X, Lin T, Gu J, et al. Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene. Int J Oncol 2003;22:1241-5.
13. Gu J, Kagawa S, Takakura M, et al. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. Cancer Res 2000;60:5359-64.
14. Zhang L, Gu J, Lin T, Huang X, Roth JA, Fang B. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. Gene Ther 2002;9:1262-70.
15. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320-3.
16. Miller CR, Buchsbaum DJ, Reynolds PN, et al. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 1998;58:5738-48.
17. Jee YS, Lee SG, Lee JC, et al. Reduced expression of coxsackievirus and adenovirus receptor (CAR) in tumor tissue compared to normal epithelium in head and neck squamous cell carcinoma patients. Anticancer Res 2002;22:2629-34.
18. Kim M, Sumerel LA, Belousova N, et al. The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br J Cancer 2003;88:1411-6.
19. Dmitriev I, Krasnykh V, Miller CR, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 1998;72:9706-13.
20. Wickham TJ, Tzeng E, Shears LL 2nd, et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 1997;71:8221-9.
21. Koch P, Guo ZS, Kagawa S, Gu J, Roth JA, Fang B. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system. Mol Ther 2001;3:278-83.
22. Marini FC, Shayakhmetov D, Lieber A, Andreeff M. Advances in gene transfer into hematopoietic stem cells by adenoviral vectors. Expert Opin Biol 2002;2:847-56.
23. Fang B, Ji L, Bouvet M, Roth JA. Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery. J Biol Chem 1998;273:4972-5.
24. Pearson AS, Koch PE, Atkinson N, et al. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines. Clin Cancer Res 1999;5:4208-13.
25. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817-27.
26. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998;273:2926-30.
27. Armeanu S, Lauer UM, Smirnow I, et al. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Cancer Res 2003;63:2369-72.
28. Wickham TJ, Roelvink PW, Brough DE, Kovesdi I. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nature Biotech 1996;14:1570-3.
29. Gu J, Andreeff M, Roth JA, Fang B. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity. Gene Ther 2002;9:30-7.